Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Ascletis Pharma-B (01672.HK) repurchased 200,000 shares for HK$1.3428 million on October 13.
13/10/2026
Zhitong Finance APP news, Ascletis Pharma-B (01672.HK) announced that on October 13, 2026, it spent HK$1.3428 million to repurchase 200,000 shares.
Latest
1 m ago
UnitedHealth (UNH.US) Q3 results beat expectations: lower medical loss ratio boosts profit, full-year earnings guidance raised again
2 m ago
Guotai Haitong (02611.HK) appoints Zhang Xinjun concurrently as the company's Chief Risk Officer
2 m ago
J&T Express-W (01519.HK) repurchased 2.6 million shares for HK$23.9515 million on October 13.
4 m ago
Renault Group CEO: If the EU does not relax its 2030 CO2 emissions targets, Renault may have to cut European production by 300,000 vehicles.
4 m ago
Chuantou Energy (600674.SH) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 4.405 billion, a year-on-year increase of 4.36%.
See all latest